Walid Abi-Saab is Chief Medical Officer at uniQure N.V. (QURE). They have made 6 open-market trades across 1 company since 2024, most recently 2026-06-30.
CIK 0001985973
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| QURE | 148,235 | $3.2M |
Shares reported on the most recent Form 4, priced at the 2026-07-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| QURE | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $46.42 | $1.4M | -2.8% | +4.6% | -42.9% |
| QURE | SELL | 2026-06-26 | 2026-06-30 | $46.86 | $67K | -11.0% | -8.5% | -15.2% |
| QURE | SELL · 10b5-1 | 2026-05-08 | 2026-05-12 | $25.06 | $1.1M | -14.2% | -5.0% | +63.3% |
| QURE | SELL | 2026-03-04 | 2026-03-06 | $9.06 | $7K | -18.2% | -3.5% | +55.5% |
| QURE | SELL | 2026-03-02 | 2026-03-04 | $9.95 | $17K | +76.3% | +92.4% | +195.9% |
| QURE | SELL | 2025-06-27 | 2025-07-01 | $13.92 | $20K | +3.0% | -1.5% | +320.4% |
| QURE | SELL | 2025-03-04 | 2025-03-05 | $10.29 | $14K | +24.6% | -23.2% | +30.0% |
| QURE | SELL | 2024-06-26 | 2024-06-28 | $4.36 | $6K | +100.7% | +75.8% | +12.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.